Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study

被引：0

作者：

Chandrasekhar, Jaya ^{[1
]}

Baber, Usman ^{[1
]}

Sartori, Samantha ^{[2
]}

Aquino, Melissa ^{[3
]}

Henry, Timothy D. ^{[4
]}

Kini, Annapoorna ^{[5
]}

Kapadia, Samir ^{[6
]}

Rao, Sunil ^{[7
]}

Weiss, Sandra ^{[8
]}

Muhlestein, Joseph B. ^{[9
]}

Poddar, Kanhaiya L. ^{[6
]}

Baker, Brian A. ^{[10
]}

Keller, Stuart Y. ^{[11
]}

Effron, Mark B. ^{[11
]}

Chao, Jennifer ^{[2
]}

Strauss, Craig E. ^{[12
]}

DeFranco, Anthony ^{[13
]}

Weintraub, William ^{[8
]}

Mehran, Roxana ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] Mt Sinai Sch Med, New York, NY USA

[3] Icahn Med Mt Sinai, New York, NY USA

[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[5] Mt Sinai, New York, NY USA

[6] Cleveland Clin, Cleveland, OH 44106 USA

[7] Duke Univ, Med Ctr, Durham, NC USA

[8] Christiana Care Hlth Syst, Newark, DE USA

[9] Intermt Med Ctr, Murray, UT USA

[10] Daiichi Sankyo, Parsippany, NJ USA

[11] Eli Lilly & Co, Indianapolis, IN 46285 USA

[12] Abbott NW Hosp, Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA

[13] Aurora Cardiovasc Serv, Milwaukee, WI USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 15期

关键词：

Acute coronary syndromes; Angioplasty; Antiplatelet therapy;

D O I：

10.1016/j.jacc.2015.08.234

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-219

引用

页码：B84 / B85

页数：2

共 50 条

[41] Prasugrel vs. clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: results of the ISAR-SHOCK registry
Orban, M.
Mayer, K.
Morath, T.
Bernlochner, I.
Schulz, S.
Mehilli, J.
Schunkert, H.
Laugwitz, K. -L.
Sibbing, D.
Kastrati, A.
EUROPEAN HEART JOURNAL, 2014, 35 : 352 - 352
[42] Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry
Zeymer, U.
Hochadel, M.
Schaechinger, V.
Zahn, R.
EUROPEAN HEART JOURNAL, 2022, 43 : 1388 - 1388
[43] TICAGRELOR VERSUS PRASUGREL IN ACUTE CORONARY SYNDROME PATIENTS WITH HIGH ON CLOPIDOGREL TREATMENT PLATELET REACTIVITY POST PCI: A PHARMACODYNAMIC STUDY
Alexopoulos, Dimitrios
Xanthopoulou, Ioanna
Mavronasiou, Eleni
Galati, Anastasia
Kassimis, George
Theodoropoulos, Konstantinos C.
Makris, George
Damelou, Anastasia
Tsigkas, Grigorios
Davlouros, Periklis
Hahalis, George
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E350 - E350
[44] IMPACT OF SMOKING STATUS ON CLINICAL OUTCOMES WITH PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES MANAGED WITHOUT REVASCULARIZATION: INSIGHTS FROM THE TRILOGY ACS TRIAL
Cornel, J. H.
Ohman, E. Magnus
Neely, Benjamin
Clemmensen, Peter
Sritara, Piyamitr
Zamoryakhin, Dmitry
Armstrong, Paul
Prabhakaran, Dorairaj
White, Harvey
Fox, Keith
Gurbel, Paul
Roe, Matthew
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E159 - E159
[45] Impact and use of prasugrel versus Clopidogrel as a function of age among patients with acute coronary syndrome undergoing percutaneous coronary intervention
Chandrasekhar, J.
Baber, U.
Sartori, S.
Aquino, M.
Henry, T.
Rao, S.
Snyder, C.
Weintraub, W.
Effron, M.
Pocock, S.
Keller, S.
Kini, A.
Strauss, C.
Mehran, R.
Kapadia, S.
EUROPEAN HEART JOURNAL, 2016, 37 : 1164 - 1164
[46] Temporal Associations Between Myocardial Infarction, Major Bleeding and Mortality Risk in ACS Patients Undergoing PCI: Insights from the PROMETHEUS Cohort
Baber, Usman
Chao, Jennifer
Chandrasekhar, Jaya
Sartori, Samantha
Aquino, Melissa
Kini, Annapoorna
Rao, Sunil
Weintraub, William
Weiss, Sandra
Strauss, Craig E.
Kapadia, Samir
Henry, Timothy D.
DeFranco, Anthony
Muhlestein, Joseph B.
Toma, Catalin
Pocock, Stuart J.
Keller, Stuart Y.
Effron, Mark B.
Baker, Brian A.
Mehran, Roxana
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B199 - B200
[47] Associations between Stent Diameter and Clinical Outcomes in ACS PCI Using Second Generation Drug-Eluting Stents: From the PROMETHEUS Study
Qadeer, Abdul
Chandrasekhar, Jaya
Baber, Usman
Sartori, Samantha
Ge, Zhen
Farhan, Serdar
Sharma, Madhav
Kini, Annapoorna
Rao, Sunil
Kapadia, Samir
Henry, Timothy
Muhlestein, Joseph
Effron, Mark
Weintraub, William
Weiss, Sandra
Strauss, Craig
DeFranco, Anthony
Toma, Catalin
Keller, Stuart
Baker, Brian
Pocock, Stuart
Mehran, Roxana
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B316 - B317
[48] Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study
Perez de Prado, Armando
Cid, Belen
Carrillo Saez, Pilar
Diego, Alejandro
Cuellas, Carlos
Lopez-Otero, Diego
Cordero, Alberto
Lopez-Benito, Maria
Ocaranza-Sanchez, Raymundo
Rodriguez-Gabella, Tania
Frutos, Araceli
Estevez-Loureiro, Rodrigo
Merchan Gomez, Soraya
Trillo, Ramiro
Lopez Palop, Ramon
Fernandez-Vazquez, Felipe
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B148 - B148
[49] COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND PLANNED PCI: RESULTS FROM THE TRITON-TIMI 38 TRIAL FROM THE GERMAN PERSPECTIVE
Mahoney, E. M.
Wang, K.
McCollam, P. L.
Schmitt, C.
Cohen, D. J.
VALUE IN HEALTH, 2009, 12 (07) : A328 - A329
[50] Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study
Bernlochner, Isabell
Mayer, Katharina
Orban, Martin
Morath, Tanja
Jaitner, Juliane
Roessner, Lisa
Gross, Lisa
Laugwitz, Karl-Ludwig
Kastrati, Adnan
Sibbing, Dirk
PLATELETS, 2016, 27 (08) : 796 - 804

← 1 2 3 4 5 →